Samsara BioCapital »

Abivax SA F shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.1M 850k 10.70

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Rayzebio
Cargo Therapeutics (CRGX)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Neurogene (NGNE)
Graphite Bio
Nkarta (NKTX)
Acelyrin (SLRN)
Zymeworks Del (ZYME)
Lyra Therapeutics (LYRA)
Syros Pharmaceuticals Com New (SYRS)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Hillevax (HLVX)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Abivax SA F

Blackstone Group
Cormorant Asset Management
Commodore Capital
Dr. Jeffrey R. Jay, M.D.
Franklin Resources
Nantahala Capital Management
VR Adviser
Samsara BioCapital
Citadel Advisors
Henderson Group
Point72 Asset Management
Rosalind Advisors
Polar Securities
Millennium Management
Kennedy Capital Management

View all funds holding Abivax SA F